ST Haiwang
SZSE · 000078
Market Cap$4.4B
Revenue$25.2B
P/E Ratio5.4
Employees6734
Listed OnSZSE
Ticker000078
IndustryDrug Manufacturers - Specialty & Generic
CEO / ExecMr. Feng Zhang
HeadquartersShenzhen
MarketMainland China
Websitewww.neptunusbio.com
Overview
Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines, infusion products, and western medicine preparations in China. The company provides oryzanol tablets, chlorpheniramine maleate tablets, estazolam tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and other medical research and development work. It also distributes drugs, medical devices, and other medica
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.